Analysis of psychiatrists' prescription of opioid, benzodiazepine, and buprenorphine in Medicare Part D in the United States
Trends psychiatry psychother. (Impr.)
;
42(1): 48-54, Jan.-Mar. 2020. tab, graf
Artigo
em Inglês
| LILACS
| ID: biblio-1099399
ABSTRACT
Abstract Introduction The opioid epidemic is a severe problem in the world, especially in the United States, where prescription opioid overdose accounts for a quarter of drug overdose deaths. Objective To describe psychiatrists' prescription of opioid, benzodiazepine, and buprenorphine in the United States. Methods We conducted a retrospective cross-sectional study of the 2016 Medicare Part D claims data and analyzed psychiatrists' prescriptions of 1) opioids; 2) benzodiazepines, whose concurrent prescription with opioids can cause overdose death; 3) buprenorphine, a partial opioid agonist for treating opioid addiction; 4) and naltrexone microsphere, a once-monthly injectable opioid antagonist to prevent relapse to opioid dependence. Prescribers with 11 or more claims were included in the analysis. Results In Medicare Part D in 2016, there were a total of 1,131,550 prescribers accounting for 1,480,972,766 total prescriptions and 78,145,305 opioid prescriptions, including 25,528 psychiatrists (2.6% of all prescribers) accounting for 44,684,504 total prescriptions (3.0% of all prescriptions) and 131,115 opioid prescriptions (0.2% of all opioid prescriptions). Psychiatrists accounted for 17.3% of benzodiazepine, 16.3% of buprenorphine, and 33.4% of naltrexone microsphere prescriptions. The opioid prescription rate of psychiatrists was much lower than that of all prescribers (0.3 vs 5.3%). The buprenorphine prescription rate of psychiatrists was much higher than that of all prescribers (2.3 vs. 0.1%). There was a substantial geographical variation across the United States. Conclusions The results show that, proportionally, psychiatrists have lower rates of opioid prescription and higher rates of benzodiazepine and buprenorphine prescription.
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Prescrições de Medicamentos
/
Psiquiatria
/
Benzodiazepinas
/
Padrões de Prática Médica
/
Buprenorfina
/
Medicare Part D
/
Analgésicos Opioides
/
Antagonistas de Entorpecentes
Tipo de estudo:
Estudo observacional
Limite:
Adulto
/
Humanos
País/Região como assunto:
América do Norte
Idioma:
Inglês
Revista:
Trends psychiatry psychother. (Impr.)
Assunto da revista:
Psiquiatria
Ano de publicação:
2020
Tipo de documento:
Artigo
País de afiliação:
Estados Unidos
Instituição/País de afiliação:
Christ Health/US
/
Samford University/US
/
University of Washington/US
Similares
MEDLINE
...
LILACS
LIS